Algae inch ahead in the race to produce the next generation of biofuels

WHEN BP branded itself as “Beyond Petroleum”, and the fashionable colour among oil companies was green, Exxon Mobil stood aloof from the rush to embrace alternative sources of energy. Indeed Rex Tillerson, the firm’s chief executive, once humorously referred to biofuels as “moonshine”. Now, when some of the enthusiasts are having second thoughts and scaling back on alternatives, Exxon seems to be going the opposite way yet again. On July 14th the oil giant said it would put $300m into what is probably the biggest effort so far to create a new generation of biofuels—with a further $300m to come if things go well.

The beneficiary of this largesse is Synthetic Genomics, a firm based in San Diego that is the commercial vehicle of Craig Venter (pictured above). Dr Venter may be familiar to readers as the former head of Celera Genomics, which ran a privately financed version of the human genome project during the late 1990s, and before that as the leader of the team which produced the first genetic sequence of a living organism (a bacterium called Haemophilus influenzae). In this case, though, the money will be thrown at neither people nor bacteria, but algae. …